Last 12 months
Inside the activity.
1 purchase rows · 3 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 1 | 0 |
| Jan 2026 | 0 | 3 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 02, 2020 Filed Jan 7, 2020 01:07 UTC |
Kishimoto Takashi KeiChief Scientific Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 140,000 | $0.00 Strike: $2.30 | $0.00 |
DisclosureSEC source: 0001453687-20-000012 · wf-form4_157835925407457.xml · derivative · entry 1 Kishimoto Takashi Kei · CIK 0001676930 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,000 Underlying: Common Stock · 140,000 shares Expires 2030-01-01 F1 · derivative.exercise_date: This option will vest as to 25% on January 2, 2021. The remainder of the underlying shares will vest in 36 equal monthly installments thereafter. Read SEC document |
| January 02, 2020 Filed Jan 7, 2020 01:08 UTC |
Kogan ElonaGeneral Counsel
|
GrantEmployee Stock Option (right to buy) · Derivative | 140,000 | $0.00 Strike: $2.30 | $0.00 |
DisclosureSEC source: 0001453687-20-000013 · wf-form4_157835927771425.xml · derivative · entry 1 Kogan Elona Esq. · CIK 0001679971 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,000 Underlying: Common Stock · 140,000 shares Expires 2030-01-01 F1 · derivative.exercise_date: This option will vest as to 25% on January 2, 2021. The remainder of the underlying shares will vest in 36 equal monthly installments thereafter. Read SEC document |
| January 02, 2020 Filed Jan 7, 2020 01:07 UTC |
Johnston Lloyd P.COO and SVP, R&D
|
GrantEmployee Stock Option (right to buy) · Derivative | 140,000 | $0.00 Strike: $2.30 | $0.00 |
DisclosureSEC source: 0001453687-20-000011 · wf-form4_157835923174735.xml · derivative · entry 1 Johnston Lloyd P. · CIK 0001676905 · COO and SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,000 Underlying: Common Stock · 140,000 shares Expires 2030-01-01 F1 · derivative.exercise_date: This option will vest as to 25% on January 2, 2021. The remainder of the underlying shares will vest in 36 equal monthly installments thereafter. Read SEC document |
| January 02, 2020 Filed Jan 7, 2020 01:07 UTC |
Dahms Bradford D.Chief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 140,000 | $0.00 Strike: $2.30 | $0.00 |
DisclosureSEC source: 0001453687-20-000010 · wf-form4_157835920999505.xml · derivative · entry 1 Dahms Bradford D. · CIK 0001787307 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,000 Underlying: Common Stock · 140,000 shares Expires 2030-01-01 F1 · derivative.exercise_date: This option will vest as to 25% on January 2, 2021. The remainder of the underlying shares will vest in 36 equal monthly installments thereafter. Read SEC document |
| December 23, 2019 Filed Dec 26, 2019 22:30 UTC |
SPRINGER TIMOTHY ADirector · 10% owner
|
GrantWarrants · Derivative | 1,970,443 | $0.13 Strike: $1.46 | $246,305.38 |
DisclosureSEC source: 0001104659-19-076222 · a4.xml · derivative · entry 4 SPRINGER TIMOTHY A · CIK 0001055624 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,970,443 Underlying: Common Stock · 1,970,443 shares Expires 2024-12-23 F1 · ownership.nature: Held by TAS Partners LLC. The reporting person is the managing member of TAS Partners LLC. The reporting person disclaims beneficial ownership of the securities held by TAS Partners LLC except to the extent of his pecuniary interest therein, if any. Read SEC document |
| December 23, 2019 Filed Dec 26, 2019 22:30 UTC |
SPRINGER TIMOTHY ADirector · 10% owner
|
GrantCommon Stock | 3,940,887 | $1.46 | $5,753,695.02 |
DisclosureSEC source: 0001104659-19-076222 · a4.xml · nonDerivative · entry 1 SPRINGER TIMOTHY A · CIK 0001055624 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 5,486,463 F1 · ownership.nature: Held by TAS Partners LLC. The reporting person is the managing member of TAS Partners LLC. The reporting person disclaims beneficial ownership of the securities held by TAS Partners LLC except to the extent of his pecuniary interest therein, if any. Read SEC document |
| December 23, 2019 Filed Dec 26, 2019 22:30 UTC |
COX CARRIE SMITHDirector
|
GrantWarrants · Derivative | 32,840 | $0.13 Strike: $1.46 | $4,105.00 |
DisclosureSEC source: 0001104659-19-076221 · a4.xml · derivative · entry 2 COX CARRIE SMITH · CIK 0001110753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,840 Underlying: Common Stock · 32,840 shares Expires 2024-12-23 Read SEC document |
| December 23, 2019 Filed Dec 26, 2019 22:30 UTC |
COX CARRIE SMITHDirector
|
GrantCommon Stock | 65,681 | $1.46 | $95,894.26 |
DisclosureSEC source: 0001104659-19-076221 · a4.xml · nonDerivative · entry 1 COX CARRIE SMITH · CIK 0001110753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,681 Read SEC document |
| December 23, 2019 Filed Dec 26, 2019 22:30 UTC |
BARABE TIMOTHY CDirector
|
GrantWarrants · Derivative | 32,840 | $0.13 Strike: $1.46 | $4,105.00 |
DisclosureSEC source: 0001104659-19-076223 · a4.xml · derivative · entry 2 BARABE TIMOTHY C · CIK 0001237409 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,840 Underlying: Common Stock · 32,840 shares Expires 2024-12-23 Read SEC document |
| December 23, 2019 Filed Dec 26, 2019 22:30 UTC |
BARABE TIMOTHY CDirector
|
GrantCommon Stock | 65,681 | $1.46 | $95,894.26 |
DisclosureSEC source: 0001104659-19-076223 · a4.xml · nonDerivative · entry 1 BARABE TIMOTHY C · CIK 0001237409 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,173 Read SEC document |
| December 23, 2019 Filed Dec 26, 2019 22:29 UTC |
Myers Scott DunsethDirector
|
GrantWarrants · Derivative | 19,704 | $0.13 Strike: $1.46 | $2,463.00 |
DisclosureSEC source: 0001104659-19-076220 · a4.xml · derivative · entry 2 Myers Scott Dunseth · CIK 0001356256 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,704 Underlying: Common Stock · 19,704 shares Expires 2024-12-23 Read SEC document |
| December 23, 2019 Filed Dec 26, 2019 22:29 UTC |
Myers Scott DunsethDirector
|
GrantCommon Stock | 39,409 | $1.46 | $57,537.14 |
DisclosureSEC source: 0001104659-19-076220 · a4.xml · nonDerivative · entry 1 Myers Scott Dunseth · CIK 0001356256 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,845 Read SEC document |
| December 12, 2019 Filed Dec 17, 2019 00:56 UTC |
SPRINGER TIMOTHY ADirector · 10% owner
|
OtherCommon Stock | 1,237,028 | $0.00 | $0.00 |
DisclosureSEC source: 0001453687-19-000171 · edgar.xml · nonDerivative · entry 1 SPRINGER TIMOTHY A · CIK 0001055624 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,293,625 F1 · kind: On December 12, 2019, the Springer Charitable Trust (the "Trust"), a charitable remainder trust to which the reporting person is a beneficiary, made a distribution to the reporting person of 1,237,028 shares of the issuer's common stock in partial satisfaction of the Trust's obligation to pay the reporting person the remainder of the assets of the Trust and in connection with the anticipated termination of the Trust. Read SEC document |
| December 02, 2019 Filed Dec 3, 2019 16:20 UTC |
Brunn CarstenDirector · President and CEO
|
SaleCommon Stock | 14,272 | $1.53 | $21,809.04 |
DisclosureSEC source: 0001453687-19-000168 · wf-form4_157540798248948.xml · nonDerivative · entry 2 Brunn Carsten · CIK 0001760229 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,914 F2 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees. F3 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $1.50 to $1.57. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 01, 2019 Filed Dec 3, 2019 16:20 UTC |
Brunn CarstenDirector · President and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 43,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001453687-19-000168 · wf-form4_157540798248948.xml · derivative · entry 3 Brunn Carsten · CIK 0001760229 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,250 Underlying: Common Stock · 43,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F4 · derivative.exercise_date: These restricted stock units vested as to 25% on December 1, 2019. The remainder of the units will vest in twelve substantially equal quarterly installments thereafter. The restricted stock units have no expiration date. F4 · derivative.expiration_date: These restricted stock units vested as to 25% on December 1, 2019. The remainder of the units will vest in twelve substantially equal quarterly installments thereafter. The restricted stock units have no expiration date. Read SEC document |
| December 01, 2019 Filed Dec 3, 2019 16:20 UTC |
Brunn CarstenDirector · President and CEO
|
Exercise / conversionCommon Stock | 43,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001453687-19-000168 · wf-form4_157540798248948.xml · nonDerivative · entry 1 Brunn Carsten · CIK 0001760229 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,186 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| November 20, 2019 Filed Nov 22, 2019 21:17 UTC |
COX CARRIE SMITHDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $1.32 | $0.00 |
DisclosureSEC source: 0001453687-19-000166 · wf-form4_157445744260726.xml · derivative · entry 1 COX CARRIE SMITH · CIK 0001110753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2029-11-19 F1 · derivative.exercise_date: The option vests in thirty-six (36) substantially equal monthly installments over three years following the date of grant. Read SEC document |
| October 07, 2019 Filed Oct 9, 2019 16:19 UTC |
Brunn CarstenDirector · President and CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 400,000 | $0.00 Strike: $1.75 | $0.00 |
DisclosureSEC source: 0001453687-19-000145 · wf-form4_157065234617939.xml · derivative · entry 1 Brunn Carsten · CIK 0001760229 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock · 400,000 shares Expires 2029-10-06 F1 · derivative.exercise_date: This option shall vest as to 50% of the shares on October 7, 2020, and the remaining 50% of the shares on October 7, 2021. Read SEC document |
| October 07, 2019 Filed Oct 9, 2019 16:20 UTC |
Smolinski StephenChief Commercial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 180,000 | $0.00 Strike: $1.75 | $0.00 |
DisclosureSEC source: 0001453687-19-000148 · wf-form4_157065241992844.xml · derivative · entry 1 Smolinski Stephen · CIK 0001721031 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,000 Underlying: Common Stock · 180,000 shares Expires 2029-10-06 F1 · derivative.exercise_date: This option shall vest as to 50% of the shares on October 7, 2020, and the remaining 50% of the shares on October 7, 2021. Read SEC document |
| October 07, 2019 Filed Oct 9, 2019 20:20 UTC |
Kishimoto Takashi KeiChief Scientific Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 180,000 | $0.00 Strike: $1.75 | $0.00 |
DisclosureSEC source: 0001453687-19-000147 · wf-form4_157065239599056.xml · derivative · entry 1 Kishimoto Takashi Kei · CIK 0001676930 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,000 Underlying: Common Stock · 180,000 shares Expires 2029-10-06 F1 · derivative.exercise_date: This option shall vest as to 50% of the shares on October 7, 2020, and the remaining 50% of the shares on October 7, 2021. Read SEC document |
| October 07, 2019 Filed Oct 9, 2019 20:19 UTC |
Johnston Lloyd P.COO and SVP, R&D
|
GrantEmployee Stock Option (right to buy) · Derivative | 180,000 | $0.00 Strike: $1.75 | $0.00 |
DisclosureSEC source: 0001453687-19-000146 · wf-form4_157065237102298.xml · derivative · entry 1 Johnston Lloyd P. · CIK 0001676905 · COO and SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,000 Underlying: Common Stock · 180,000 shares Expires 2029-10-06 F1 · derivative.exercise_date: This option shall vest as to 50% of the shares on October 7, 2020, and the remaining 50% of the shares on October 7, 2021. Read SEC document |
| September 03, 2019 Filed Sep 6, 2019 01:48 UTC |
SPRINGER TIMOTHY ADirector · 10% owner
|
OtherCommon Stock | 1,237,028 | $0.00 | $0.00 |
DisclosureSEC source: 0001453687-19-000138 · edgar.xml · nonDerivative · entry 1 SPRINGER TIMOTHY A · CIK 0001055624 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 0 F1 · kind: Reflects a liquidating distribution by Leukon Investments, LP to its partners. F2 · ownership.nature: Held by Leukon Investments, LP. F4 · ownership.nature: LKST, Inc. is the general partner of Leukon Investments, LP. Timothy Springer is the president of LKST, Inc. and the managing member of TAS Partners LLC. The Reporting Person disclaims beneficial ownership of the securities held by Leukon Investments, LP and TAS Partners LLC except to the extent of his pecuniary interest therein, if any. Read SEC document |
| September 03, 2019 Filed Sep 5, 2019 21:29 UTC |
Dahms Bradford D.Chief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 400,000 | $0.00 Strike: $1.70 | $0.00 |
DisclosureSEC source: 0001453687-19-000133 · wf-form4_156771897844321.xml · derivative · entry 1 Dahms Bradford D. · CIK 0001787307 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock · 400,000 shares Expires 2029-09-02 F1 · derivative.exercise_date: This option vests as to 25% on September 3, 2020, and the remainder of the underlying shares will vest in 36 equal monthly installments thereafter. Read SEC document |
| August 20, 2019 Filed Aug 20, 2019 20:33 UTC |
SPRINGER TIMOTHY ADirector · 10% owner
|
GrantCommon Stock | 1,100,000 | $1.81 | $1,991,000.00 |
DisclosureSEC source: 0001453687-19-000126 · wf-form4_156633317611747.xml · nonDerivative · entry 2 SPRINGER TIMOTHY A · CIK 0001055624 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 1,545,576 F1 · ownership.nature: LKST, Inc. is the general partner of Leukon Investments LP. Timothy Springer is the president of LKST, Inc. and the managing member of TAS Partners, LLC. The Reporting Person disclaims beneficial ownership of the securities held by Leukon Investments LP and TAS Partners, LLC except to the extent of his pecuniary interest therein, if any. F2 · ownership.nature: Held by TAS Partners, LLC Read SEC document |
| August 20, 2019 Filed Aug 20, 2019 20:33 UTC |
SPRINGER TIMOTHY ADirector · 10% owner
|
GrantCommon Stock | 1,600,000 | $1.81 | $2,896,000.00 |
DisclosureSEC source: 0001453687-19-000126 · wf-form4_156633317611747.xml · nonDerivative · entry 1 SPRINGER TIMOTHY A · CIK 0001055624 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,056,597 Read SEC document |
| August 20, 2019 Filed Aug 20, 2019 16:29 UTC |
ZENNER PATRICK JDirector
|
GrantCommon Stock | 55,248 | $1.81 | $99,998.88 |
DisclosureSEC source: 0001453687-19-000120 · wf-form4_156633298315611.xml · nonDerivative · entry 1 ZENNER PATRICK J · CIK 0001139036 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,248 Read SEC document |
| August 20, 2019 Filed Aug 20, 2019 16:31 UTC |
Brunn CarstenDirector · President and CEO
|
GrantCommon Stock | 41,436 | $1.81 | $74,999.16 |
DisclosureSEC source: 0001453687-19-000121 · wf-form4_156633307237124.xml · nonDerivative · entry 1 Brunn Carsten · CIK 0001760229 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,436 Read SEC document |
| August 20, 2019 Filed Aug 20, 2019 16:32 UTC |
Smolinski StephenChief Commercial Officer
|
GrantCommon Stock | 13,812 | $1.81 | $24,999.72 |
DisclosureSEC source: 0001453687-19-000125 · wf-form4_156633315653823.xml · nonDerivative · entry 1 Smolinski Stephen · CIK 0001721031 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,812 Read SEC document |
| August 20, 2019 Filed Aug 20, 2019 20:32 UTC |
Myers Scott DunsethDirector
|
GrantCommon Stock | 41,436 | $1.81 | $74,999.16 |
DisclosureSEC source: 0001453687-19-000124 · wf-form4_156633313666723.xml · nonDerivative · entry 1 Myers Scott Dunseth · CIK 0001356256 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,436 Read SEC document |
| August 20, 2019 Filed Aug 20, 2019 20:32 UTC |
Kogan ElonaGeneral Counsel
|
GrantCommon Stock | 82,872 | $1.81 | $149,998.32 |
DisclosureSEC source: 0001453687-19-000123 · wf-form4_156633311554335.xml · nonDerivative · entry 1 Kogan Elona Esq. · CIK 0001679971 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,872 F1 · balance_after: Total shares reported includes 50,000 shares underlying unvested restricted stock units. Read SEC document |
| August 20, 2019 Filed Aug 20, 2019 20:31 UTC |
Kishimoto Takashi KeiChief Scientific Officer
|
GrantCommon Stock | 50,000 | $1.81 | $90,500.00 |
DisclosureSEC source: 0001453687-19-000122 · wf-form4_156633309274523.xml · nonDerivative · entry 1 Kishimoto Takashi Kei · CIK 0001676930 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,114 Read SEC document |
| August 14, 2019 Filed Aug 16, 2019 20:18 UTC |
SPRINGER TIMOTHY ADirector · 10% owner
|
PurchaseCommon Stock | 10,000 | $1.74 | $17,415.00 |
DisclosureSEC source: 0001453687-19-000112 · wf-form4_156598667111543.xml · nonDerivative · entry 1 SPRINGER TIMOTHY A · CIK 0001055624 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By wife Disclosed balance after: 86,418 F1 · price: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.69 to $1.75. The Reporting Person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| August 13, 2019 Filed Aug 15, 2019 20:19 UTC |
BARABE TIMOTHY CDirector
|
PurchaseCommon Stock | 10,000 | $1.72 | $17,200.00 |
DisclosureSEC source: 0001453687-19-000106 · wf-form4_156590036429438.xml · nonDerivative · entry 1 BARABE TIMOTHY C · CIK 0001237409 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,492 Read SEC document |
| July 23, 2019 Filed Jul 25, 2019 20:15 UTC |
Johnston Lloyd P.COO and SVP, R&D
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $0.47 | $0.00 |
DisclosureSEC source: 0001453687-19-000084 · wf-form4_156408571299475.xml · derivative · entry 2 Johnston Lloyd P. · CIK 0001676905 · COO and SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2019-07-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: All shares underlying this option are fully vested. Read SEC document |
| July 23, 2019 Filed Jul 25, 2019 20:15 UTC |
Johnston Lloyd P.COO and SVP, R&D
|
Exercise / conversionCommon Stock | 10,000 | $0.47 | $4,700.00 |
DisclosureSEC source: 0001453687-19-000084 · wf-form4_156408571299475.xml · nonDerivative · entry 1 Johnston Lloyd P. · CIK 0001676905 · COO and SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,606 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 15, 2019 Filed Jul 17, 2019 16:18 UTC |
Schecter Alison D.Chief Medical Officer
|
GrantCommon Stock · Derivative | 350,000 | $0.00 Strike: $1.71 | $0.00 |
DisclosureSEC source: 0001453687-19-000082 · wf-form4_156339467597510.xml · derivative · entry 1 Schecter Alison D. · CIK 0001782448 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 350,000 Underlying: Common Stock · 350,000 shares Expires 2029-07-14 F1 · derivative.exercise_date: This option vests as to 25% on July 15, 2020, and the remainder of the underlying shares will vest in 36 equal monthly installments thereafter. Read SEC document |
| June 14, 2019 Filed Jun 18, 2019 20:22 UTC |
SPRINGER TIMOTHY ADirector · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $2.10 | $0.00 |
DisclosureSEC source: 0001453687-19-000074 · wf-form4_156088932766321.xml · derivative · entry 1 SPRINGER TIMOTHY A · CIK 0001055624 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2029-06-13 F1 · derivative.exercise_date: The option vests in full on the earlier of June 14, 2020 or the day immediately prior to the company's 2020 annual meeting of stockholders. Read SEC document |
| June 14, 2019 Filed Jun 18, 2019 16:22 UTC |
ZENNER PATRICK JDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $2.10 | $0.00 |
DisclosureSEC source: 0001453687-19-000075 · wf-form4_156088934496556.xml · derivative · entry 1 ZENNER PATRICK J · CIK 0001139036 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2029-06-13 F1 · derivative.exercise_date: The option vests in full on the earlier of June 14, 2020 or the day immediately prior to the company's 2020 annual meeting of stockholders. Read SEC document |
| June 14, 2019 Filed Jun 18, 2019 20:21 UTC |
Nashat AmirDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $2.10 | $0.00 |
DisclosureSEC source: 0001453687-19-000072 · wf-form4_156088928720786.xml · derivative · entry 1 Nashat Amir · CIK 0001575843 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2029-06-13 F1 · derivative.exercise_date: The option vests in full on the earlier of June 14, 2020 or the day immediately prior to the company's 2020 annual meeting of stockholders. Read SEC document |
| June 14, 2019 Filed Jun 18, 2019 20:22 UTC |
Sallin AymericDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $2.10 | $0.00 |
DisclosureSEC source: 0001453687-19-000073 · wf-form4_156088930979080.xml · derivative · entry 1 Sallin Aymeric · CIK 0001677660 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2029-06-13 F1 · derivative.exercise_date: The option vests in full on the earlier of June 14, 2020 or the day immediately prior to the company's 2020 annual meeting of stockholders. Read SEC document |
| June 14, 2019 Filed Jun 18, 2019 20:20 UTC |
BARABE TIMOTHY CDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $2.10 | $0.00 |
DisclosureSEC source: 0001453687-19-000069 · wf-form4_156088923042633.xml · derivative · entry 1 BARABE TIMOTHY C · CIK 0001237409 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2029-06-13 F1 · derivative.exercise_date: The option vests in full on the earlier of June 14, 2020 or the day immediately prior to the company's 2020 annual meeting of stockholders. Read SEC document |
| June 14, 2019 Filed Jun 18, 2019 20:21 UTC |
Myers Scott DunsethDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $2.10 | $0.00 |
DisclosureSEC source: 0001453687-19-000071 · wf-form4_156088926892404.xml · derivative · entry 1 Myers Scott Dunseth · CIK 0001356256 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2029-06-13 F1 · derivative.exercise_date: The option vests in thirty-six (36) substantially equal monthly installments over three years following the date of grant. Read SEC document |
| June 14, 2019 Filed Jun 18, 2019 20:21 UTC |
Farokhzad OmidDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,404 | $0.00 Strike: $2.10 | $0.00 |
DisclosureSEC source: 0001453687-19-000070 · wf-form4_156088924977252.xml · derivative · entry 1 Farokhzad Omid · CIK 0001586852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,404 Underlying: Common Stock · 15,404 shares Expires 2029-06-13 F1 · derivative.exercise_date: The option vests in full on the earlier of June 14, 2020 or the day immediately prior to the company's 2020 annual meeting of stockholders. Read SEC document |
| March 25, 2019 Filed Mar 27, 2019 20:17 UTC |
Kogan ElonaGeneral Counsel
|
GrantStock Option (Right to Buy) · Derivative | 400,000 | $0.00 Strike: $2.29 | $0.00 |
DisclosureSEC source: 0001679971-19-000005 · wf-form4_155371785653312.xml · derivative · entry 2 Kogan Elona Esq. · CIK 0001679971 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock · 400,000 shares Expires 2029-03-24 F2 · derivative.exercise_date: This option vests as to 25% on March 20, 2020. The remainder of the underlying shares will vest in 36 equal monthly installments thereafter. Read SEC document |
| March 25, 2019 Filed Mar 27, 2019 20:17 UTC |
Kogan ElonaGeneral Counsel
|
GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001679971-19-000005 · wf-form4_155371785653312.xml · nonDerivative · entry 1 Kogan Elona Esq. · CIK 0001679971 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 F1 · kind: Represents shares underlying Restricted Stock Unit awards, which vest, and the underlying shares become issuable, upon achievement of specified performance goals. Read SEC document |
| February 25, 2019 Filed Feb 27, 2019 16:30 UTC |
Brunn CarstenDirector · President and CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 330,000 | $0.00 Strike: $2.20 | $0.00 |
DisclosureSEC source: 0001760229-19-000002 · wf-form4_155130300495416.xml · derivative · entry 1 Brunn Carsten · CIK 0001760229 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 330,000 Underlying: Common Stock · 330,000 shares Expires 2029-02-24 F1 · derivative.exercise_date: This option will vest as to 25% on February 25, 2020. The remainder of the underlying shares will vest in 36 equal monthly installments thereafter. Read SEC document |
| January 25, 2019 Filed Jan 29, 2019 21:37 UTC |
Nashat AmirDirector
|
PurchaseCommon Stock | 1,125,756 | $1.50 | $1,688,634.00 |
DisclosureSEC source: 0000899243-19-002116 · doc4.xml · nonDerivative · entry 4 Nashat Amir · CIK 0001575843 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,676,234 F7 · ownership.nature: The reportable securities are owned directly by Polaris Venture Partners V, L.P. ("PVP V"). PVM V is the general partner of PVP V. PVM V disclaims beneficial ownership of these securities and this report shall not be deemed an admission that PVM V is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of its pecuniary interest therein. F8 · ownership.nature: Each of Flint and McGuire are the managing members of PVM V. The Reporting Person, who is a member of the Issuer's Board of Directors, is a member of PVM V. Each of Flint, McGuire and the Reporting Person, in their respective capacities with regard to PVM V, may be deemed to have shared voting and dispositive power of the shares held by PVP V. Each of Flint, McGuire and the Reporting Person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Read SEC document |
| January 25, 2019 Filed Jan 29, 2019 21:37 UTC |
Nashat AmirDirector
|
PurchaseCommon Stock | 11,258 | $1.50 | $16,887.00 |
DisclosureSEC source: 0000899243-19-002116 · doc4.xml · nonDerivative · entry 3 Nashat Amir · CIK 0001575843 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 26,760 F5 · ownership.nature: The reportable securities are owned directly by Polaris Venture Partners Special Founders' Fund V, L.P. ("PVPSFF V"). PVM V is the general partner of PVPSFF V. PVM V disclaims beneficial ownership of these securities and this report shall not be deemed an admission that PVM V is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of its pecuniary interest therein. F6 · ownership.nature: Each of Flint and McGuire are the managing members of PVM V. The Reporting Person, who is a member of the Issuer's Board of Directors, is a member of PVM V. Each of Flint, McGuire and the Reporting Person, in their respective capacities with regard to PVM V, may be deemed to have shared voting and dispositive power of the shares held by PVPSFF V. Each of Flint, McGuire and the Reporting Person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Read SEC document |
| January 25, 2019 Filed Jan 29, 2019 21:37 UTC |
Nashat AmirDirector
|
PurchaseCommon Stock | 7,711 | $1.50 | $11,566.50 |
DisclosureSEC source: 0000899243-19-002116 · doc4.xml · nonDerivative · entry 2 Nashat Amir · CIK 0001575843 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 18,329 F3 · ownership.nature: The reportable securities are owned directly by Polaris Venture Partners Founders' Fund V, L.P. ("PVPFF V"). PVM V is the general partner of PVPFF V. PVM V disclaims beneficial ownership of these securities and this report shall not be deemed an admission that PVM V is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of its pecuniary interest therein. F4 · ownership.nature: Each of Flint and McGuire are the managing members of PVM V. The Reporting Person, who is a member of the Issuer's Board of Directors, is a member of PVM V. Each of Flint, McGuire and the Reporting Person, in their respective capacities with regard to PVM V, may be deemed to have shared voting and dispositive power of the shares held by PVPFF V. Each of Flint, McGuire and the Reporting Person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Read SEC document |
| January 25, 2019 Filed Jan 29, 2019 21:37 UTC |
Nashat AmirDirector
|
PurchaseCommon Stock | 21,941 | $1.50 | $32,911.50 |
DisclosureSEC source: 0000899243-19-002116 · doc4.xml · nonDerivative · entry 1 Nashat Amir · CIK 0001575843 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 52,156 F1 · ownership.nature: The reportable securities are owned directly by Polaris Venture Partners Entrepreneurs' Fund V, L.P. ("PVPE V"). Polaris Venture Management Co. V, L.L.C. ("PVM V") is the general partner of PVPE V. PVM V disclaims beneficial ownership of these securities and this report shall not be deemed an admission that PVM V is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of its pecuniary interest therein. F2 · ownership.nature: Each of Jonathan A. Flint ("Flint") and Terrance G. McGuire ("McGuire") are the managing members of PVM V. The Reporting Person, who is a member of the Issuer's Board of Directors, is a member of PVM V. Each of Flint, McGuire and the Reporting Person, in their respective capacities with regard to PVM V, may be deemed to have shared voting and dispositive power of the shares held by PVPE V. Each of Flint, McGuire and the Reporting Person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.